Phase 3 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 80 years of age (either male or female)
- People who are already scheduled to have a craniotomy (a type of brain surgery) to remove a tumor
- People who have given written consent to participate, or whose legal decision-maker has given written consent on their behalf
Who may not be able to join:
- People who have a current or past history of blood clot conditions, including deep vein thrombosis (blood clots in the veins)
- People with a known pre-existing condition that affects blood clotting, such as hemophilia, Von Willebrand disease, or other clotting factor deficiencies
- People with reduced kidney function below a certain level, or those currently on dialysis for kidney failure (confirm specific kidney function thresholds with the trial site)
- People who are currently pregnant or breastfeeding
- People with a very high body mass index (BMI of 40 or above), which is classified as Class 3 or high-risk obesity
- People whose surgery is classified as an emergency craniotomy, or who are having a smaller or different type of skull surgery (mini craniotomy or craniectomy)
- People who have already had an embolization procedure (a treatment that blocks blood flow to the tumor) before their surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stephen Lownie, MD, Nova Scotia Health Authority- Queen Elizabeth II HSC
Phone: 902-473-6449
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Estimated intraoperative blood loss; Reoperation or disability or death due to intracranial hemorrhage within 30 days
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.